U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285070) titled 'Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis' on Dec. 09.
Brief Summary: The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Non-infectious Anterior Uveitis
Intervention:
DRUG: Tacrolimus ophthalmic solution
high and low dose treatment will be compared over 6 weeks treatment
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novaliq GmbH
Published by HT Digital Content Services with permissio...